Loss-of-function SMAD3 mutations are strongly associated with LDS type 3 (aneurysms-osteoarthritis syndrome) but were found by Regalado et al. to also be responsible for 2% of ns-TAAD with a mean age at dissection of 42 years old[62,63]. This evidence concerns the gene SMAD3 and aneurysm.